This indicates that despite elevated levels of these BAs, the regulatory function of FXR, which is crucial for maintaining BA homeostasis, modulating inflammation, and integrity of the intestinal barrier, is impaired in IBD patients [125]. Here, NR1H4 is linked to inflammatory bowel disease.